MRK insider transactions
Merck & Company Inc. (MRK) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for MRK
- SEC Form 4 filed by Seidman Christine E4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Glocer Thomas H4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Coe Mary Ellen4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 3 filed by new insider Foard Brian3 - Merck & Co., Inc. (0000310158) (Issuer)
- Chief Marketing Officer Guindo Chirfi sold $1,214,562 worth of shares (10,000 units at $121.46), decreasing direct ownership by 14% to 60,615 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Executive VP & President, MRL Li Dean Y sold $1,202,844 worth of shares (10,235 units at $117.52), decreasing direct ownership by 10% to 92,035 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Chief Marketing Officer Guindo Chirfi sold $1,184,101 worth of shares (10,000 units at $118.41), decreasing direct ownership by 12% to 70,615 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP, General Counsel Zachary Jennifer exercised 121,573 shares at a strike of $119.15 and sold $14,485,690 worth of shares (121,573 units at $119.15) (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP,Chief Info&Digital Officer Williams David Michael exercised 5,000 shares at a strike of $77.62 and sold $609,525 worth of shares (5,000 units at $121.91), decreasing direct ownership by 0.00% to 30,838 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- SVP Fin. - Global Controller Smart Dalton E. Iii exercised 4,000 shares at a strike of $62.07 and sold $765,920 worth of shares (6,400 units at $119.67), decreasing direct ownership by 23% to 8,205 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- President, U.S. Market Oosthuizen Johannes Jacobus sold $1,827,992 worth of shares (15,000 units at $121.87), decreasing direct ownership by 41% to 21,197 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP & CFO Litchfield Caroline exercised 41,997 shares at a strike of $53.06 and sold $5,023,312 worth of shares (41,997 units at $119.61), increasing direct ownership by 0.00% to 90,192 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Executive VP & President, MRL Li Dean Y exercised 15,087 shares at a strike of $56.04 and sold $1,791,824 worth of shares (15,087 units at $118.77) (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Chief Marketing Officer Guindo Chirfi sold $2,437,676 worth of shares (20,000 units at $121.88), decreasing direct ownership by 20% to 80,615 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP&Pres, Merck Animal Heallth Deluca Richard R. sold $4,557,025 worth of shares (37,685 units at $120.92), decreasing direct ownership by 19% to 160,174 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Chairman, CEO & President Davis Robert M sold $5,599,327 worth of shares (47,434 units at $118.04), decreasing direct ownership by 10% to 443,602 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP, General Counsel Zachary Jennifer was granted 11,583 shares, increasing direct ownership by 20% to 68,916 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP,Chief Info&Digital Officer Williams David Michael was granted 6,112 shares, increasing direct ownership by 25% to 30,838 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- SVP Fin. - Global Controller Smart Dalton E. Iii was granted 1,066 shares, increasing direct ownership by 11% to 10,605 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- President, Human Health Int?l Romanelli Joseph was granted 5,703 shares, increasing direct ownership by 25% to 28,739 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- President, U.S. Market Oosthuizen Johannes Jacobus was granted 5,026 shares, increasing direct ownership by 16% to 36,197 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP & CFO Litchfield Caroline was granted 15,852 shares, increasing direct ownership by 21% to 90,192 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Executive VP & President, MRL Li Dean Y was granted 20,469 shares, increasing direct ownership by 25% to 102,270 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Chief Marketing Officer Guindo Chirfi was granted 9,865 shares, increasing direct ownership by 11% to 100,615 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP&Pres, Merck Animal Heallth Deluca Richard R. was granted 12,264 shares, increasing direct ownership by 7% to 197,859 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Chairman, CEO & President Davis Robert M was granted 47,434 shares, increasing direct ownership by 11% to 491,036 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Exe V-P & Pres. MMD Chattopadhyay Sanat was granted 13,880 shares (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Seidman Christine E4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Glocer Thomas H4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Coe Mary Ellen4 - Merck & Co., Inc. (0000310158) (Issuer)
- Chief Comm. & Public Afrs Ofcr Downing Cristal N sold $616,395 worth of shares (7,085 units at $87.00), closing all direct ownership in the company (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP,Chief Info&Digital Officer Williams David Michael sold $720,040 worth of shares (8,614 units at $83.59), decreasing direct ownership by 26% to 24,578 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Seidman Christine E4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Glocer Thomas H4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Coe Mary Ellen4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP,Chief Info&Digital Officer Williams David Michael exercised 17,119 shares at a strike of $79.29 and covered exercise/tax liability with 8,432 shares, increasing direct ownership by 36% to 33,013 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Chief Marketing Officer Guindo Chirfi exercised 36,903 shares at a strike of $79.29 and covered exercise/tax liability with 18,175 shares, increasing direct ownership by 27% to 89,234 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Seidman Christine E4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Glocer Thomas H4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Coe Mary Ellen4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Warden Kathy J4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Thulin Inge G4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Seidman Christine E4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Russo Patricia F4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Rothman Paul4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Mayo Stephen4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Lavizzo-Mourey Risa J4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Karsanbhai Surendralal Lanca4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Glocer Thomas H4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Craig Pamela J.4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Coe Mary Ellen4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by Director Baker Douglas M Jr4 - Merck & Co., Inc. (0000310158) (Issuer)
- SVP Fin. - Global Controller Smart Dalton E. Iii exercised 2,050 shares at a strike of $83.18 and covered exercise/tax liability with 844 shares, increasing direct ownership by 14% to 9,539 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- SVP Fin. - Global Controller Smart Dalton E. Iii exercised 845 shares at a strike of $84.06 and covered exercise/tax liability with 290 shares, increasing direct ownership by 7% to 8,333 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- President, Human Health Int?l Romanelli Joseph exercised 4,325 shares at a strike of $83.95 and covered exercise/tax liability with 2,132 shares, increasing direct ownership by 11% to 22,946 units (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- EVP, Chief HR Officer Larson Betty D exercised 11,350 shares at a strike of $84.71 and covered exercise/tax liability with 5,153 shares (SEC Form 4)4 - Merck & Co., Inc. (0000310158) (Issuer)
- Amendment: SEC Form 4 filed by President, Human Health Int?l Romanelli Joseph4/A - Merck & Co., Inc. (0000310158) (Issuer)
- Amendment: SEC Form 4 filed by EVP, Chief HR Officer Larson Betty D4/A - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by SVP Fin. - Global Controller Smart Dalton E. Iii4 - Merck & Co., Inc. (0000310158) (Issuer)
- SEC Form 4 filed by EVP & CFO Litchfield Caroline4 - Merck & Co., Inc. (0000310158) (Issuer)